JPH0611238B2 - Method for measuring argininosuccinate or argininosuccinate lyase - Google Patents
Method for measuring argininosuccinate or argininosuccinate lyaseInfo
- Publication number
- JPH0611238B2 JPH0611238B2 JP58202423A JP20242383A JPH0611238B2 JP H0611238 B2 JPH0611238 B2 JP H0611238B2 JP 58202423 A JP58202423 A JP 58202423A JP 20242383 A JP20242383 A JP 20242383A JP H0611238 B2 JPH0611238 B2 JP H0611238B2
- Authority
- JP
- Japan
- Prior art keywords
- argininosuccinate
- acid
- measuring
- lyase
- argininosuccinic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 21
- 101710191958 Amino-acid acetyltransferase Proteins 0.000 title claims description 7
- 102000009042 Argininosuccinate Lyase Human genes 0.000 title claims description 7
- KDZOASGQNOPSCU-UHFFFAOYSA-N argininosuccinate Chemical compound OC(=O)C(N)CCCN=C(N)NC(C(O)=O)CC(O)=O KDZOASGQNOPSCU-UHFFFAOYSA-N 0.000 title claims description 6
- KDZOASGQNOPSCU-WDSKDSINSA-N Argininosuccinic acid Chemical compound OC(=O)[C@@H](N)CCC\N=C(/N)N[C@H](C(O)=O)CC(O)=O KDZOASGQNOPSCU-WDSKDSINSA-N 0.000 claims description 16
- 239000005515 coenzyme Substances 0.000 claims description 15
- 102000004452 Arginase Human genes 0.000 claims description 11
- 108700024123 Arginases Proteins 0.000 claims description 11
- 150000003222 pyridines Chemical class 0.000 claims description 11
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 claims description 10
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 8
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical group C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 7
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 claims description 3
- 102000004132 Ornithine aminotransferases Human genes 0.000 claims description 3
- 108090000691 Ornithine aminotransferases Proteins 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 2
- 102000004317 Lyases Human genes 0.000 claims 1
- 108090000856 Lyases Proteins 0.000 claims 1
- 102100023167 Argininosuccinate lyase Human genes 0.000 description 14
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 14
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 8
- 108020001898 pyrroline-5-carboxylate reductase Proteins 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 6
- 229930064664 L-arginine Natural products 0.000 description 6
- 235000014852 L-arginine Nutrition 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000004202 carbamide Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 229960003104 ornithine Drugs 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 4
- 239000001530 fumaric acid Substances 0.000 description 4
- 229950006238 nadide Drugs 0.000 description 4
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229960002989 glutamic acid Drugs 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229960002429 proline Drugs 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- AKYHKWQPZHDOBW-UHFFFAOYSA-N (5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol Chemical compound OS(O)(=O)=O.C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 AKYHKWQPZHDOBW-UHFFFAOYSA-N 0.000 description 2
- NXOIMAMHRHDCFR-UHFFFAOYSA-N 2,3-dihydro-1h-pyrrole-2-carboxylic acid Chemical compound OC(=O)C1CC=CN1 NXOIMAMHRHDCFR-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000001576 FEMA 2977 Substances 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229930182821 L-proline Natural products 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 2
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 229940099596 manganese sulfate Drugs 0.000 description 2
- 235000007079 manganese sulphate Nutrition 0.000 description 2
- 239000011702 manganese sulphate Substances 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 2
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 2
- 229960001327 pyridoxal phosphate Drugs 0.000 description 2
- 229960003110 quinine sulfate Drugs 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- -1 α-ketoglutarate pyrroline-5-carboxylic acid Chemical compound 0.000 description 2
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000001019 Inborn Errors Metabolism Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 101710148753 Ornithine aminotransferase Proteins 0.000 description 1
- 101100013182 Oryza sativa subsp. indica OSL gene Proteins 0.000 description 1
- 101100013183 Oryza sativa subsp. japonica FL gene Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- MZZSDCJQCLYLLL-UHFFFAOYSA-N Secalonsaeure A Natural products COC(=O)C12OC3C(CC1=C(O)CC(C)C2O)C(=CC=C3c4ccc(O)c5C(=O)C6=C(O)CC(C)C(O)C6(Oc45)C(=O)OC)O MZZSDCJQCLYLLL-UHFFFAOYSA-N 0.000 description 1
- 102000008579 Transposases Human genes 0.000 description 1
- 108010020764 Transposases Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 201000003554 argininosuccinic aciduria Diseases 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 208000016245 inborn errors of metabolism Diseases 0.000 description 1
- 208000015978 inherited metabolic disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000004143 urea cycle Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
【発明の詳細な説明】 本発明はアルギニノコハク酸またはアルギニノコハク酸
リアーゼの測定法に関する。アルギニノコハク酸および
アルギニノコハク酸リアーゼ(EC4.3.2.1 Argininosucc
inate lyase,以下「ASL」という)は蛋白など含窒素
化合物の代謝産物である遊離のアンモニアを無害の尿素
に固定する尿素サイクルの構成員であり、肝臓中におい
てアルギニノコハク酸はASLの作用によりL−アルギ
ニンとフマル酸に分解され、次いでL−アルギニンはア
ルギナーゼの作用によってL−オルニチンと尿素に分解
されて、尿素は腎臓から生体外へ排泄される。アルギニ
ノコハク酸またはASLの測定はアルギニノコハク酸尿
症等の先天的代謝異常疾患の診断に有用である。The present invention relates to a method for measuring argininosuccinate or argininosuccinate lyase. Argininosuccinate and argininosuccinate lyase (EC4.3.2.1 Argininosucc
inate lyase (hereinafter referred to as “ASL”) is a member of the urea cycle that fixes free ammonia, which is a metabolite of nitrogen-containing compounds such as proteins, to harmless urea, and argininosuccinic acid in the liver is L- It is decomposed into arginine and fumaric acid, and then L-arginine is decomposed into L-ornithine and urea by the action of arginase, and urea is excreted from the kidney out of the body. Measurement of argininosuccinic acid or ASL is useful for diagnosis of inborn errors of metabolism such as argininosuccinic aciduria.
従来アルギニノコハク酸またはASLの測定は、アルギ
ニノコハク酸とASLの反応生成物の一つであるフマル
酸をその二重結合に由来する。240nmの吸収により測定
する方法〔メソッズ イン エンザイモロジィー(Meth
ods in Enzymology)第17A巻,304頁,1970年〕、同じ
くもう一つの反応生成物であるL−アルギニンにアルギ
ナーゼを作用させて生成する尿素を測定する方法〔ジャ
ーナル オブ バイオロジカル ケミストリー(J.Bio
l.Chem.)第157巻,507頁,1945年〕、14Cラベルし
たグアニジノ−L−アルギニノコハク酸を基質として用
いる方法〔メソッズ イン エンザイモロジィー(Meth
ods in Enzymology)第17A巻,326頁,1970年〕などが
知られている。しかし、これらの方法は多量の試料を必
要とすること並びに除蛋白のため遠心操作を必要とする
ことなどのため、多数検体の処理には多大の労力、時間
および試薬を要し、また感度も低いものであった。Conventionally, the measurement of argininosuccinic acid or ASL is derived from the double bond of fumaric acid, which is one of the reaction products of argininosuccinic acid and ASL. Method of measurement by absorption at 240 nm [Methods in enzymology (Meth
ods in Enzymology) 17A, 304, 1970], a method for measuring urea produced by reacting arginase with another reaction product, L-arginine [Journal of Biological Chemistry (J. Bio).
l.Chem.) 157, 507, 1945], a method using 14 C-labeled guanidino-L-argininosuccinic acid as a substrate [Methods in Enzymology (Meth
ods in Enzymology) Vol. 17A, p. 326, 1970]. However, since these methods require a large amount of sample and a centrifugation operation for deproteinization, the processing of a large number of samples requires a great deal of labor, time and reagents, and also has a high sensitivity. It was low.
本発明者らは、小児の代謝異常疾患の診断のためのマス
スクリーニングに利用できるアルギニノコハク酸または
ASLの測定法について検討したところ、被検試料にオ
ルニチン−ケト酸アミノトランスフェラーゼ〔L-オルニ
チン:2-オキソ酸アミノトランスフェラーゼ(EC 2.6.
1.13)、以下「OAT」という〕、ピロリン−5−カル
ボン酸リダクターゼ〔L-プロリン:NAD(P)+5−オ
キシドリダクターゼ(EC1.5.1.2)、以下「P5CR」
という〕、アルギナーゼ(L-アルギニンアミジノヒドロ
ラーゼ,EC3.5.3.1)、α−ケトグルタル酸、還元型ピ
リジンヌクレオチド補酵素およびアルギニノコハク酸ま
たはASLのいずれか一方を反応せしめて、反応液中の
還元型ピリジンヌクレオチド補酵素の変化を測定するこ
とにより、微量定量性、正確性、迅速性、簡便性および
多検体測定などにおける従来技術の欠点が改善されるこ
とを知り、本発明を完成したものである。The present inventors have examined a method for measuring argininosuccinate or ASL that can be used for mass screening for the diagnosis of metabolic disorders in children, and found that ornithine-keto acid aminotransferase [L-ornithine: 2- Oxo acid aminotransferase (EC 2.6.
1.13), hereinafter referred to as "OAT"], pyrroline-5-carboxylic acid reductase [L-proline: NAD (P) + 5-oxide reductase (EC1.5.1.2), hereinafter "P5CR".
], Arginase (L-arginine amidinohydrolase, EC3.5.3.1), α-ketoglutarate, reduced pyridine nucleotide coenzyme and either argininosuccinic acid or ASL are reacted to give reduced pyridine in the reaction solution. The inventors have completed the present invention, knowing that by measuring changes in nucleotide coenzymes, the drawbacks of the prior art in microquantitativeness, accuracy, speediness, simplicity, and multi-analyte measurement can be improved.
本発明法で用いる酵素はすべて公知であり、例えばアル
ギナーゼはラッド肝より〔メソッズ イン エンザイモ
ロジィー(Methods in Enzymology)第17A巻,313ペー
ジ,1970年〕、OATはバチルス スファエリカス(Ba
cillus sphaericus)菌より〔フェブス レター(FEBS
Lett.)第105巻,209ページ,1979年〕、P5CRはパ
ン酵母より〔バイオキミカ エ バイオフィジカ アク
タ(Biochim.Biophys.Acta)第613巻,318ページ,1980
年〕およびASLはストレプトコッカス・フエカリス
(Streptococcus faecalis)菌よりの酵素が例示され
る。All enzymes used in the method of the present invention are known, for example, arginase is derived from Rad liver [Methods in Enzymology 17A, 313, 1970], OAT is Bacillus sphaericus (Ba).
cillus sphaericus) [FEBS letter (FEBS
Lett.) 105, 209, 1979], P5CR is derived from baker's yeast [Biochim. Biophys. Acta] 613, 318, 1980.
And ASL are exemplified by enzymes from Streptococcus faecalis.
本発明法の反応系について詳細に説明すると、まずアル
ギニノコハク酸はASLの作用によりL−アルギニンと
フマル酸に分解され、次いでL−アルギニンはアルギナ
ーゼの作用によりL−オルニチンと尿素に分解され、L
−オルニチンはα−ケトグルタル酸の存在下OATの作
用によりグルタミン酸γ−セミアルデヒドとグルタミン
酸を生じ、さらにグルタミン酸γ−セミアルデヒドは非
酵素的にピロリン−5−カルボン酸に変化する。ピロリ
ン−5−カルボン酸は還元型ピリジンヌクレオチド補酵
素の存在下P5CRの作用のもとにプロリンを生成し、
同時に還元型ピリジンヌクレオチド補酵素は酸化型にな
る。このときの還元型ピリジンヌクレオチド補酵素の変
化、すなわちそれの減少または酸化型補酵素の増加を測
定することによりアルギニノコハク酸またはASLが定
量される。還元型ピリジンヌクレオチド補酵素の例とし
ては還元型ニコチンアミドアデニンジヌクレオチド(以
下「NADH」という)または還元型ニコチンアミドア
デニンジヌクレオチドリン酸(以下「NADPH」とい
う)が挙げられる。これら補酵素の測定は、好ましくは
還元型ピリジンヌクレオチド補酵素の減少を340nm付近
における吸光度あるいは螢光強度の変化から測定するこ
とが望ましく、特に微量定量のためには螢光強度を測定
するのがよい。The reaction system of the method of the present invention will be described in detail. First, argininosuccinic acid is decomposed into L-arginine and fumaric acid by the action of ASL, and then L-arginine is decomposed into L-ornithine and urea by the action of arginase.
-Ornithine produces glutamic acid γ-semialdehyde and glutamic acid by the action of OAT in the presence of α-ketoglutarate, and glutamic acid γ-semialdehyde is nonenzymatically changed to pyrroline-5-carboxylic acid. Pyroline-5-carboxylic acid produces proline under the action of P5CR in the presence of reduced pyridine nucleotide coenzyme,
At the same time, the reduced pyridine nucleotide coenzyme becomes oxidized. Argininosuccinic acid or ASL is quantified by measuring the change in reduced pyridine nucleotide coenzyme at this time, that is, the decrease thereof or the increase of oxidized coenzyme. Examples of the reduced pyridine nucleotide coenzyme include reduced nicotinamide adenine dinucleotide (hereinafter referred to as “NADH”) or reduced nicotinamide adenine dinucleotide phosphate (hereinafter referred to as “NADPH”). The measurement of these coenzymes is preferably performed by measuring the decrease of reduced pyridine nucleotide coenzyme from the change in absorbance or fluorescence intensity at around 340 nm, and in particular, it is preferable to measure the fluorescence intensity for microquantification. Good.
以上の、本発明法の反応式を示せば次のとおりである。The reaction equation of the method of the present invention is as follows.
(1)アルギニノコハク酸→L−アルギニン+フマル酸 (2)L-アルギニン+H2O→L-オルニチン+尿素 (3)L-オルニチン+α−ケトグルタル酸 ピロリン-5−カルボン酸+L-グルタミン酸 (4)ピロリン-5−カルボン酸+NAD(P)H+2H+→L-プロリ
ン+NAD(P)+ 以上述べた如く、本発明法はOAT、P5CR、アル
ギナーゼ、α−ケトグルタル酸、還元型ピリジンヌクレ
オチド補酵素およびASLを必須として用いるアルギニ
ノコハク酸の測定法およびOAT、P5CR、アルギ
ナーゼ、α−ケトグルタル酸、還元型ピリジンヌクレオ
チド補酵素およびアルギニノコハク酸を必須として用い
るASLの測定法である。本発明法ではOATなど転位
酵素の補酵素として通常用いられるピリドキサールリン
酸は必要ではなく、むしろこれの使用はNAD(P)H
の螢光測定に悪影響を及ぼす。本発明者らはα−ケトグ
ルタル酸の添加がピリドキサールリン酸の作用を代償す
ることを見いだした結果、螢光測定による微量定量が可
能となったものである。(1) Argininosuccinic acid → L-arginine + fumaric acid (2) L-arginine + H 2 O → L-ornithine + urea (3) L-ornithine + α-ketoglutarate pyrroline-5-carboxylic acid + L-glutamic acid (4) pyrroline -5-carboxylic acid + NAD (P) H + 2H + → L-proline + NAD (P) + As described above, the method of the present invention comprises OAT, P5CR, arginase, α-ketoglutarate, and reduced pyridine nucleotide coenzyme. And ASL are essential measurement methods for argininosuccinic acid and OSL, P5CR, arginase, α-ketoglutarate, reduced pyridine nucleotide coenzyme and argininosuccinic acid are essential measurement methods for ASL. The method of the present invention does not require pyridoxal phosphate, which is commonly used as a coenzyme for transposases such as OAT, but rather uses it for NAD (P) H
Adversely affect the fluorescence measurement of. The present inventors have found that the addition of α-ketoglutaric acid compensates for the action of pyridoxal phosphate, and as a result, it has become possible to perform microquantification by fluorescence measurement.
測定試料は全血、血清、血漿、尿および組織抽出物など
いずれも用いられるが、マススクリーニングのために
は、血液を濾紙にしみこませて乾燥したのち血色素を固
定化したいわゆる血液ろ紙を用いるのがよい。血色素の
固定化法はエーテル(または塩化メチレン):水:アセ
トン:アルコールからなる組成物を用いる方法が確実、
迅速であることから好ましい。このようにして調製した
血液ろ紙を径3mm程度のディスクに打ち抜き、これを試
料として反応混合液に加えることにより、容易に測定で
きる。The measurement sample may be whole blood, serum, plasma, urine, tissue extract, etc., but for mass screening, a so-called blood filter paper on which hemopigment is immobilized after soaking blood into filter paper and drying it is used. Is good. The method of immobilizing hemoglobin is sure to use a composition consisting of ether (or methylene chloride): water: acetone: alcohol,
It is preferable because it is quick. The blood filter paper thus prepared is punched out into a disk having a diameter of about 3 mm, and this is added as a sample to the reaction mixture, whereby the measurement can be easily carried out.
以下に実施例をもって本発明を具体的に説明する。The present invention will be specifically described below with reference to examples.
実施例1 反応混合液50μ(0.1Mトリス塩酸緩衝液,pH8.0)に
次の試薬、即ち5muASL(ジグマケミカルス社製)、2
0muアルギナーゼ〔10mM硫酸マンガンを含む1.0Mグリシ
ン緩衝液(pH7.5)に溶解したものを使用〕、0.25μmol
α−ケトグルタル酸、0.5nmolジチオスレイトール、12m
uOAT、12muP5CR、5nmol NADH並びに試料と
して0〜10nmolのアルギニノコハク酸を含む各反応混合
液を37℃、1時間反応させた。反応液に水3.0mを加
えたのち0.29μM硫酸キニーネを標準液として励起波長
340nm、螢光波長450nmにおいて螢光強度を測定した。上
記反応混合液よりASLを除いた他は同様に操作して得
られた値をブランク値として、この値と上記測定値との
差をブランク値で除した値(百分率)を求め、これとア
ルギニノコハク酸濃度との関係をグラフ上にプロットし
検量線を作成したところ、図に示すとおりとなった。Example 1 50 μl of a reaction mixture (0.1 M Tris-HCl buffer, pH 8.0) was added with the following reagents, 5 mu ASL (manufactured by Sigma Chemicals), 2
0 mu arginase [Used by dissolving in 1.0 M glycine buffer solution (pH 7.5) containing 10 mM manganese sulfate], 0.25 μmol
α-ketoglutaric acid, 0.5 nmol dithiothreitol, 12 m
Each reaction mixture containing uOAT, 12 mu P5CR, 5 nmol NADH and 0-10 nmol of argininosuccinic acid as a sample was reacted at 37 ° C. for 1 hour. After adding 3.0 m of water to the reaction solution, 0.29 μM quinine sulfate standard solution was used as the excitation wavelength.
The fluorescence intensity was measured at 340 nm and a fluorescence wavelength of 450 nm. A value obtained by operating in the same manner except that ASL was removed from the above reaction mixture was used as a blank value, and the value (percentage) obtained by dividing the difference between this value and the above measured value by the blank value was obtained. When the calibration curve was created by plotting the relationship with the acid concentration on the graph, it was as shown in the figure.
次ぎに、血漿を試料として上記と同様に操作して、測定
螢光強度を検量線と対比したところ、アルギニノコハク
酸濃度は0.62mMであった。なおNADHの代わりにNA
DPHを用いても同様の結果が得られた。Next, when plasma was used as a sample and operated in the same manner as above, and the measured fluorescence intensity was compared with the calibration curve, the argininosuccinic acid concentration was 0.62 mM. NA instead of NADH
Similar results were obtained with DPH.
実施例2 新生児代謝異常のマススクリーニングに使用されている
ガスリー氏ろ紙(第一化学薬品社製)に数滴血液をしみ
こませ風乾した。これを径3mmのディスクに打ち抜き試
験管に入れた後、エーテル:水:アセトン:メタノール
の比が容量比で70:5:5:20の組成物20μを加え室
温で1時間放置して血色素の変性固定化処理を行った。
このろ紙ディスクを試料として実施例1と同様に操作し
たところ、アルギニノコハク酸濃度は0.61mMであった。Example 2 A few drops of blood were soaked in Guthrie's filter paper (manufactured by Daiichi Pure Chemicals Co., Ltd.) used for mass screening for neonatal metabolic disorders and air dried. This was punched into a disc with a diameter of 3 mm and put into a test tube, and then 20 μm of a composition having a volume ratio of ether: water: acetone: methanol of 70: 5: 5: 20 was added, and the mixture was allowed to stand at room temperature for 1 hour to remove blood pigment A denaturing immobilization treatment was performed.
When this filter paper disk was used as a sample and operated in the same manner as in Example 1, the concentration of argininosuccinic acid was 0.61 mM.
実施例3 反応混合液50μ(0.1Mトリス塩酸緩衝液,pH8.0)に
次の試薬、即ち1.0mmolアルギニノコハク酸、20muアル
ギナーゼ〔10mM硫酸マンガンを含む1.0Mグリシン緩衝
液(pH7.5)に溶解したものを使用〕、0.25μmolα−ケ
トグルタル酸、0.5nmolジチオスレイトール、12muOA
T、12muP5CR、10nmolNADH並びに血清試料を含
む反応混合液を37℃、1時間反応させた。反応液に水3.
0mを加えたのち0.29μM硫酸キニーネを標準液とし
て励起波長340nm、螢光波長450nmにおいて螢光強度を測
定し、NADHの減少量からASL活性を求めた。Example 3 50 μl of a reaction mixture (0.1 M Tris-HCl buffer, pH 8.0) was dissolved in the following reagents: 1.0 mmol argininosuccinate, 20 mu arginase [1.0 M glycine buffer containing 10 mM manganese sulfate (pH 7.5). Used)], 0.25 μmol α-ketoglutarate, 0.5 nmol dithiothreitol, 12 muOA
A reaction mixture containing T, 12 mu P5CR, 10 nmol NADH and a serum sample was reacted at 37 ° C. for 1 hour. Water in the reaction solution 3.
After adding 0 m, the fluorescence intensity was measured at an excitation wavelength of 340 nm and a fluorescence wavelength of 450 nm using 0.29 μM quinine sulfate as a standard solution, and the ASL activity was determined from the decrease amount of NADH.
図は本発明法によるアルギニノコハク酸の検量線を表す
図である。The figure shows a calibration curve of argininosuccinic acid according to the method of the present invention.
───────────────────────────────────────────────────── フロントページの続き 審判官 大高 とし子 (56)参考文献 特開 昭53−89493(JP,A) J Biol chen,第157巻,507 〜518頁,1945年 ─────────────────────────────────────────────────── ─── Continuation of the front page Judge Judge Toshiko Otaka (56) Reference JP-A-53-89493 (JP, A) J Biol chen, Volume 157, pp. 507-518, 1945
Claims (2)
ンスフェラーゼ、ピロリン−5−カルボン酸リダクター
ゼ、アルギナーゼ、α−ケトグルタル酸、還元型ピリジ
ンヌクレオチド補酵素およびアルギニノコハク酸リアー
ゼまたはアルギニノコハク酸のいずれか一方を反応せし
め還元型ピリジンヌクレオチド補酵素の変化を測定する
ことを特徴とするアルギニノコハク酸またはアルギニノ
コハク酸リアーゼの測定法。1. A test sample is reacted with one of ornithine-keto acid aminotransferase, pyroline-5-carboxylic acid reductase, arginase, α-ketoglutarate, reduced pyridine nucleotide coenzyme and argininosuccinate lyase or argininosuccinate. A method for measuring argininosuccinic acid or argininosuccinic acid lyase, which comprises measuring a change in a pseudo-reducing pyridine nucleotide coenzyme.
型ニコチンアミドアデニンジヌクレオチドまたは還元型
ニコチンアミドアデニンジヌクレオチドリン酸である特
許請求の範囲第1項記載のアルギニノコハク酸またはア
ルギニノコハク酸リアーゼの測定法。2. The method for measuring argininosuccinic acid or argininosuccinate lyase according to claim 1, wherein the reduced pyridine nucleotide coenzyme is reduced nicotinamide adenine dinucleotide or reduced nicotinamide adenine dinucleotide phosphate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58202423A JPH0611238B2 (en) | 1983-10-27 | 1983-10-27 | Method for measuring argininosuccinate or argininosuccinate lyase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58202423A JPH0611238B2 (en) | 1983-10-27 | 1983-10-27 | Method for measuring argininosuccinate or argininosuccinate lyase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6094099A JPS6094099A (en) | 1985-05-27 |
| JPH0611238B2 true JPH0611238B2 (en) | 1994-02-16 |
Family
ID=16457260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58202423A Expired - Lifetime JPH0611238B2 (en) | 1983-10-27 | 1983-10-27 | Method for measuring argininosuccinate or argininosuccinate lyase |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0611238B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108318687A (en) * | 2018-01-29 | 2018-07-24 | 青岛浩铂生物科技有限公司 | A kind of reagent and preparation method thereof for detecting arginyl succinic acid lyases in serum |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5915639B2 (en) * | 1977-01-18 | 1984-04-10 | 健夫 松沢 | Method for measuring ornithine or ornithine aminotransferase |
-
1983
- 1983-10-27 JP JP58202423A patent/JPH0611238B2/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| JBiolchen,第157巻,507〜518頁,1945年 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6094099A (en) | 1985-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH04278099A (en) | Method and composition for highly sensitively determining amount of ammonia, alpha-amino acid or alpha-keto acid | |
| JPH0698036B2 (en) | Selective quantification of amino acids | |
| JPH0611238B2 (en) | Method for measuring argininosuccinate or argininosuccinate lyase | |
| JP3036711B2 (en) | Highly sensitive lactic acid or pyruvic acid quantification method and composition for quantification | |
| JP3023700B2 (en) | Highly sensitive method and composition for determination of L-malic acid or oxaloacetic acid | |
| JP2000232898A (en) | Quantitative analysis of substance and reagent therefor | |
| EP0387697A2 (en) | Determination of aminotranferases | |
| JPS61225000A (en) | Method for quantifying 3α-hydroxysteroids and reagents used therefor | |
| JPS59173098A (en) | Determination of arginine or arginase | |
| JPS60210998A (en) | Test composition, test kit and method for enzymatical measurement of inorganic phosphate | |
| JPS61173799A (en) | Method of determining activity of substrate or enzyme | |
| US4349625A (en) | Method for assaying fatty acids | |
| JPH10225300A (en) | Highly sensitive determination of glucose or adp | |
| KR20240126617A (en) | Method for Detecting Hydrogen Peroxide using Glucose Meter | |
| JPS62232400A (en) | Determination of ornithine carbamoyl transferase or citrulline | |
| JPH10136997A (en) | Determination of biological material | |
| JPH02145196A (en) | Method for determining magnesium | |
| CN115420694A (en) | Glutamate dehydrogenase determination kit | |
| JP3449649B2 (en) | Determination method and reagent for sodium acetate | |
| JPS63129996A (en) | Quantitative determination of l-amino acid and alpha-keto acid | |
| JP2980811B2 (en) | Determination method of ammonium ion | |
| JP2001149092A (en) | How to measure homocysteine | |
| JP3227486B2 (en) | Copper measurement method | |
| JP3143289B2 (en) | Chlorine ion determination method | |
| CN117705738A (en) | Monoamine oxidase (MAO) content detection kit |